SARS-CoV-2 Omicron has extensive but incomplete escape of Pfizer BNT162b2 elicited neutralization and requires ACE2 for infection
Sandile Cele, Laurelle Jackson, David S. Khoury, Khadija Khan, Thandeka Moyo-Gwete, Houriiyah Tegally, James Emmanuel San, Deborah Cromer, Cathrine Scheepers, Daniel Amoako, Farina Karim, Mallory Bernstein, Gila Lustig, Derseree Archary, Muneerah Smith, Yashica Ganga, Zesuliwe Jule, Kajal Reedoy, Shi-Hsia Hwa, Jennifer Giandhari, Jonathan M. Blackburn, Bernadett I. Gosnell, Salim S. Abdool Karim, Willem Hanekom, NGS-SA, COMMIT-KZN Team, Anne von Gottberg, Jinal Bhiman, Richard J. Lessells, Mahomed-Yunus S. Moosa, View ORCID ProfileMiles P. Davenport, View ORCID ProfileTulio de Oliveira, View ORCID ProfilePenny L. Moore, View ORCID ProfileAlex Sigal
doi: https://doi.org/10.1101/2021.12.08.21267417
Sandile Cele
1Africa Health Research Institute, Durban, South Africa
2School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, South Africa
Laurelle Jackson
1Africa Health Research Institute, Durban, South Africa
David S. Khoury
3Kirby Institute, University of New South Wales, Sydney, Australia
Khadija Khan
1Africa Health Research Institute, Durban, South Africa
2School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, South Africa
Thandeka Moyo-Gwete
4National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa
5MRC Antibody Immunity Research Unit, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
Houriiyah Tegally
6KwaZulu-Natal Research Innovation and Sequencing Platform, Durban, South Africa
7Centre for Epidemic Response and Innovation, School of Data Science and Computational Thinking, Stellenbosch University, Stellenbosch, South Africa
James Emmanuel San
6KwaZulu-Natal Research Innovation and Sequencing Platform, Durban, South Africa
Deborah Cromer
3Kirby Institute, University of New South Wales, Sydney, Australia
Cathrine Scheepers
4National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa
5MRC Antibody Immunity Research Unit, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
Daniel Amoako
4National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa
Farina Karim
1Africa Health Research Institute, Durban, South Africa
2School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, South Africa
Mallory Bernstein
1Africa Health Research Institute, Durban, South Africa
Gila Lustig
8Centre for the AIDS Programme of Research in South Africa, Durban, South Africa
Derseree Archary
8Centre for the AIDS Programme of Research in South Africa, Durban, South Africa
9Department of Medical Microbiology, University of KwaZulu-Natal, Durban, South Africa
Muneerah Smith
10Department of Integrative Biomedical Sciences, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa
Yashica Ganga
1Africa Health Research Institute, Durban, South Africa
Zesuliwe Jule
1Africa Health Research Institute, Durban, South Africa
Kajal Reedoy
1Africa Health Research Institute, Durban, South Africa
Shi-Hsia Hwa
1Africa Health Research Institute, Durban, South Africa
11Division of Infection and Immunity, University College London, London, UK
Jennifer Giandhari
6KwaZulu-Natal Research Innovation and Sequencing Platform, Durban, South Africa
Jonathan M. Blackburn
10Department of Integrative Biomedical Sciences, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa
12Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa
Bernadett I. Gosnell
13Department of Infectious Diseases, Nelson R. Mandela School of Clinical Medicine, University of KwaZulu-Natal, Durban, South Africa
Salim S. Abdool Karim
8Centre for the AIDS Programme of Research in South Africa, Durban, South Africa
14Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, United States
Willem Hanekom
1Africa Health Research Institute, Durban, South Africa
11Division of Infection and Immunity, University College London, London, UK
Anne von Gottberg
4National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa
5MRC Antibody Immunity Research Unit, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
Jinal Bhiman
4National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa
5MRC Antibody Immunity Research Unit, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
Richard J. Lessells
6KwaZulu-Natal Research Innovation and Sequencing Platform, Durban, South Africa
7Centre for Epidemic Response and Innovation, School of Data Science and Computational Thinking, Stellenbosch University, Stellenbosch, South Africa
8Centre for the AIDS Programme of Research in South Africa, Durban, South Africa
Mahomed-Yunus S. Moosa
13Department of Infectious Diseases, Nelson R. Mandela School of Clinical Medicine, University of KwaZulu-Natal, Durban, South Africa
Miles P. Davenport
3Kirby Institute, University of New South Wales, Sydney, Australia
Tulio de Oliveira
6KwaZulu-Natal Research Innovation and Sequencing Platform, Durban, South Africa
7Centre for Epidemic Response and Innovation, School of Data Science and Computational Thinking, Stellenbosch University, Stellenbosch, South Africa
8Centre for the AIDS Programme of Research in South Africa, Durban, South Africa
15Department of Global Health, University of Washington, Seattle, USA
Penny L. Moore
4National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa
5MRC Antibody Immunity Research Unit, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
8Centre for the AIDS Programme of Research in South Africa, Durban, South Africa
12Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa
Alex Sigal
1Africa Health Research Institute, Durban, South Africa
2School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, South Africa
16Max Planck Institute for Infection Biology, Berlin, Germany
Data Availability
All data produced in the present work are contained in the manuscript
Posted December 17, 2021.
SARS-CoV-2 Omicron has extensive but incomplete escape of Pfizer BNT162b2 elicited neutralization and requires ACE2 for infection
Sandile Cele, Laurelle Jackson, David S. Khoury, Khadija Khan, Thandeka Moyo-Gwete, Houriiyah Tegally, James Emmanuel San, Deborah Cromer, Cathrine Scheepers, Daniel Amoako, Farina Karim, Mallory Bernstein, Gila Lustig, Derseree Archary, Muneerah Smith, Yashica Ganga, Zesuliwe Jule, Kajal Reedoy, Shi-Hsia Hwa, Jennifer Giandhari, Jonathan M. Blackburn, Bernadett I. Gosnell, Salim S. Abdool Karim, Willem Hanekom, NGS-SA, COMMIT-KZN Team, Anne von Gottberg, Jinal Bhiman, Richard J. Lessells, Mahomed-Yunus S. Moosa, Miles P. Davenport, Tulio de Oliveira, Penny L. Moore, Alex Sigal
medRxiv 2021.12.08.21267417; doi: https://doi.org/10.1101/2021.12.08.21267417
SARS-CoV-2 Omicron has extensive but incomplete escape of Pfizer BNT162b2 elicited neutralization and requires ACE2 for infection
Sandile Cele, Laurelle Jackson, David S. Khoury, Khadija Khan, Thandeka Moyo-Gwete, Houriiyah Tegally, James Emmanuel San, Deborah Cromer, Cathrine Scheepers, Daniel Amoako, Farina Karim, Mallory Bernstein, Gila Lustig, Derseree Archary, Muneerah Smith, Yashica Ganga, Zesuliwe Jule, Kajal Reedoy, Shi-Hsia Hwa, Jennifer Giandhari, Jonathan M. Blackburn, Bernadett I. Gosnell, Salim S. Abdool Karim, Willem Hanekom, NGS-SA, COMMIT-KZN Team, Anne von Gottberg, Jinal Bhiman, Richard J. Lessells, Mahomed-Yunus S. Moosa, Miles P. Davenport, Tulio de Oliveira, Penny L. Moore, Alex Sigal
medRxiv 2021.12.08.21267417; doi: https://doi.org/10.1101/2021.12.08.21267417
Subject Area
Subject Areas
- Addiction Medicine (394)
- Allergy and Immunology (706)
- Anesthesia (197)
- Cardiovascular Medicine (2887)
- Dermatology (247)
- Emergency Medicine (433)
- Epidemiology (12630)
- Forensic Medicine (10)
- Gastroenterology (814)
- Genetic and Genomic Medicine (4490)
- Geriatric Medicine (411)
- Health Economics (717)
- Health Informatics (2874)
- Health Policy (1059)
- Hematology (380)
- HIV/AIDS (912)
- Medical Education (418)
- Medical Ethics (115)
- Nephrology (466)
- Neurology (4258)
- Nursing (228)
- Nutrition (625)
- Oncology (2230)
- Ophthalmology (636)
- Orthopedics (255)
- Otolaryngology (323)
- Pain Medicine (272)
- Palliative Medicine (83)
- Pathology (491)
- Pediatrics (1183)
- Primary Care Research (489)
- Public and Global Health (6842)
- Radiology and Imaging (1504)
- Respiratory Medicine (910)
- Rheumatology (431)
- Sports Medicine (377)
- Surgery (476)
- Toxicology (60)
- Transplantation (206)
- Urology (176)